Turkish Journal of Medical Sciences
Abstract
Background/aim: Liver damage is a significant complication that increases mortality and morbidity in primary immunodeficiencies (PIDs). Although biopsy is the gold standard, the fibrosis-4 (FIB-4) scoring system is a noninvasive method for diagnosing liver fibrosis. In this study, we investigated the value of the FIB-4 score as an early indicator of liver damage in patients with primary antibody deficiencies (PADs).
Materials and methods: Of 52 patients, 40 had common variable immunodeficiency (CVID), 12 had immunoglobulin G subclass deficiency (IgG-SGD), and they were enrolled in the study. Patients were divided into hematology, rheumatology + dermatology, gastroenterology/hepatology, and respiratory diseases groups based on their clinical phenotypes. FIB-4 score calculation and transient elastography were used to detect liver complications.
Results: FIB-4 scores were significantly higher in CVID patients than in those with SGD (p = 0.003), and were also elevated in PAD patients with hematology and gastroenterology/hepatology phenotypes compared with rheumatology + dermatology and respiratory phenotypes (p < 0.001). In the gastroenterology/hepatology group patients, FIB-4 scores showed a strong positive correlation with elastography values (r = 0.825, p < 0.001). FIB-4 and elastography showed moderate to good agreement (κ = 0.41–0.60) for detecting significant fibrosis, and FIB-4 was also a valuable indicator in high-risk patients (≥3.25).
Conclusions: This study is the first to show that FIB-4 may serve as a practical and noninvasive indicator of liver damage in PADs.
Author ORCID Identifier
HACI UĞUR MUŞABAK: 0000-0003-1511-7634
TUBA ERDOĞAN: 0000-0002-3143-2442
EMRE ÖZBEK: 0000-0001-6345-8607
DUDU DURAK ANŞİN: 0000-0001-8461-0153
ZUMRUD MEHTİ: 0009-0005-6082-9448
DOI
10.55730/1300-0144.6219
Keywords
Common variable immunodeficiency, fibrosis-4 index, liver damage
First Page
847
Last Page
859
Publisher
The Scientific and Technological Research Council of Türkiye (TÜBİTAK)
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Recommended Citation
MUŞABAK, H, ERDOĞAN, T, ÖZBEK, E, DURAK ANŞİN, D. M, & MEHTİ, Z (2026). A high FIB-4 score may be an early sign of severe liver damage in patients with primary antibody deficiencies. Turkish Journal of Medical Sciences 56 (3): 847-859. https://doi.org/10.55730/1300-0144.6219